34.14
price down icon0.23%   -0.08
after-market Handel nachbörslich: 34.14
loading
Schlusskurs vom Vortag:
$34.22
Offen:
$33.86
24-Stunden-Volumen:
1.22M
Relative Volume:
0.57
Marktkapitalisierung:
$5.42B
Einnahmen:
$264.79M
Nettoeinkommen (Verlust:
$-14.36M
KGV:
-310.36
EPS:
-0.11
Netto-Cashflow:
$-28.11M
1W Leistung:
-6.47%
1M Leistung:
+6.16%
6M Leistung:
-11.12%
1J Leistung:
+49.54%
1-Tages-Spanne:
Value
$33.59
$34.78
1-Wochen-Bereich:
Value
$33.10
$36.89
52-Wochen-Spanne:
Value
$22.61
$46.48

Tg Therapeutics Inc Stock (TGTX) Company Profile

Name
Firmenname
Tg Therapeutics Inc
Name
Telefon
(212) 554-4484
Name
Adresse
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Name
Mitarbeiter
352
Name
Twitter
@TGTherapeutics
Name
Nächster Verdiensttermin
2025-03-03
Name
Neueste SEC-Einreichungen
Name
TGTX's Discussions on Twitter

Vergleichen Sie TGTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TGTX
Tg Therapeutics Inc
34.14 5.43B 264.79M -14.36M -28.11M -0.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-06 Fortgesetzt H.C. Wainwright Buy
2025-07-10 Fortgesetzt Goldman Neutral
2024-10-29 Eingeleitet TD Cowen Buy
2023-08-02 Hochstufung Goldman Sell → Neutral
2023-06-26 Fortgesetzt Jefferies Buy
2022-05-20 Eingeleitet BofA Securities Underperform
2022-02-23 Bestätigt B. Riley Securities Buy
2021-11-15 Herabstufung Goldman Neutral → Sell
2021-04-20 Eingeleitet Goldman Neutral
2021-04-19 Bestätigt H.C. Wainwright Buy
2020-09-01 Eingeleitet JP Morgan Overweight
2020-08-11 Bestätigt H.C. Wainwright Buy
2020-06-05 Eingeleitet Evercore ISI Outperform
2020-01-17 Bestätigt H.C. Wainwright Buy
2019-11-27 Fortgesetzt B. Riley FBR Buy
2019-02-06 Fortgesetzt Jefferies Buy
2018-09-25 Herabstufung Raymond James Strong Buy → Outperform
2018-03-09 Bestätigt B. Riley FBR, Inc. Buy
2017-12-01 Fortgesetzt B. Riley FBR, Inc. Buy
2017-11-14 Fortgesetzt H.C. Wainwright Buy
2017-04-25 Eingeleitet Jefferies Buy
2017-03-06 Bestätigt FBR & Co. Outperform
2016-10-06 Fortgesetzt Brean Capital Buy
2016-05-27 Eingeleitet SunTrust Buy
2015-12-01 Eingeleitet FBR Capital Outperform
2015-09-09 Eingeleitet Raymond James Strong Buy
2015-08-12 Fortgesetzt H.C. Wainwright Buy
2015-06-19 Bestätigt Brean Capital Buy
2014-12-11 Bestätigt ROTH Capital Buy
2014-12-10 Bestätigt ROTH Capital Buy
Alle ansehen

Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten

pulisher
04:33 AM

How TG Therapeutics Inc. stock compares to industry benchmarksMarket Risk Analysis & Growth Focused Stock Reports - newser.com

04:33 AM
pulisher
03:49 AM

TG Therapeutics Inc. stock chart pattern explainedPortfolio Value Report & Safe Entry Trade Signal Reports - newser.com

03:49 AM
pulisher
12:31 PM

Published on: 2025-10-14 02:23:58 - newser.com

12:31 PM
pulisher
Oct 13, 2025

Is TG Therapeutics Inc. forming a bottoming baseWeekly Risk Report & Daily Chart Pattern Signals - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What candlestick patterns are forming on TG Therapeutics Inc.Market Trend Review & Growth Focused Stock Reports - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How risky is TG Therapeutics Inc. (NKB2) stock compared to peersMarket Growth Review & Growth-Oriented Investment Plans - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What dividend safety score for TG Therapeutics Inc. stockPortfolio Risk Summary & Real-Time Market Sentiment Reports - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Published on: 2025-10-13 09:09:08 - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Published on: 2025-10-13 08:45:12 - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

TG Therapeutics, Inc. (TGTX) Investor Outlook: Exploring a 29% Upside in the Biotech Sector - DirectorsTalk Interviews

Oct 13, 2025
pulisher
Oct 13, 2025

Can TG Therapeutics Inc. stock resist market sell offs2025 Trading Volume Trends & Risk Managed Trade Strategies - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

Is TG Therapeutics Inc. stock bottoming outJuly 2025 Market Mood & High Yield Equity Trading Tips - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Market reaction to TG Therapeutics Inc.’s recent newsMarket Performance Recap & Risk Controlled Stock Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What makes TG Therapeutics Inc. (NKB2) stock appealing to growth investorsMarket Risk Analysis & High Return Stock Watch Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Is TG Therapeutics Inc. still worth holding after the dipJuly 2025 Retail & Verified Chart Pattern Trade Signals - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is TG Therapeutics Inc. reversing from oversold territoryMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

What indicators show strength in TG Therapeutics Inc.Dividend Hike & Expert Approved Momentum Trade Ideas - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Analysts Offer Predictions for TG Therapeutics Q3 Earnings - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

What analysts say about TG Therapeutics Inc stockEarnings Forecast Updates & Identify Breakout Stocks - earlytimes.in

Oct 08, 2025
pulisher
Oct 07, 2025

TG Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Strong Performance Metrics - Markets Mojo

Oct 07, 2025
pulisher
Oct 07, 2025

HC Wainwright Weighs in on TG Therapeutics FY2029 Earnings - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

TG Therapeutics raises 2025 guidance to $560M, driven by BRIUMVI adoption - MSN

Oct 06, 2025
pulisher
Oct 06, 2025

TGTX Receives 'Buy' Rating from HC Wainwright & Co. with $60 Pri - GuruFocus

Oct 06, 2025
pulisher
Oct 06, 2025

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Significant Growth Potential - DirectorsTalk Interviews

Oct 06, 2025
pulisher
Oct 06, 2025

Analyzing TG Therapeutics Inc. with risk reward ratio chartsQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Detecting support and resistance levels for TG Therapeutics Inc.July 2025 Drop Watch & Fast Moving Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 04, 2025

Institutional investors are TG Therapeutics, Inc.'s (NASDAQ:TGTX) biggest bettors and were rewarded after last week's US$176m market cap gain - Yahoo Finance

Oct 04, 2025
pulisher
Oct 04, 2025

What TG Therapeutics (TGTX)'s Six-Year BRIUMVI Safety Data Means For Shareholders - Yahoo Finance

Oct 04, 2025
pulisher
Oct 03, 2025

A Look at TG Therapeutics (TGTX) Valuation Following Positive Six-Year BRIUMVI Trial Results - Sahm

Oct 03, 2025
pulisher
Oct 03, 2025

TG Therapeutics, Inc.'s (NASDAQ:TGTX) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 5.8% Over Last Week - 富途牛牛

Oct 03, 2025
pulisher
Oct 03, 2025

Key metrics from TG Therapeutics Inc.’s quarterly dataTrade Volume Summary & Precise Buy Zone Identification - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Can TG Therapeutics Inc. stock rebound after recent weaknessBear Alert & Real-Time Stock Movement Alerts - newser.com

Oct 03, 2025
pulisher
Oct 01, 2025

What TG Therapeutics, Inc.'s (NASDAQ:TGTX) 26% Share Price Gain Is Not Telling You - Sahm

Oct 01, 2025
pulisher
Sep 29, 2025

Is TG Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Rallies & Short-Term High Return Strategies - newser.com

Sep 29, 2025

Finanzdaten der Tg Therapeutics Inc-Aktie (TGTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):